New hope for advanced lung cancer: SKB571 trial launches
NCT ID NCT07230405
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tests a new drug called SKB571 in 295 adults with advanced non-small cell lung cancer. The goal is to see if it shrinks tumors and how safe it is. Participants receive the drug alone until their cancer worsens or side effects become too severe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NON-SMALL CELL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-Sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.